JPWO2022260064A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022260064A5 JPWO2022260064A5 JP2023527886A JP2023527886A JPWO2022260064A5 JP WO2022260064 A5 JPWO2022260064 A5 JP WO2022260064A5 JP 2023527886 A JP2023527886 A JP 2023527886A JP 2023527886 A JP2023527886 A JP 2023527886A JP WO2022260064 A5 JPWO2022260064 A5 JP WO2022260064A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- formula
- salt
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021096206 | 2021-06-08 | ||
| PCT/JP2022/023076 WO2022260064A1 (ja) | 2021-06-08 | 2022-06-08 | ジヒドロピリダジン-3,5-ジオン誘導体を含有する製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022260064A1 JPWO2022260064A1 (cg-RX-API-DMAC7.html) | 2022-12-15 |
| JPWO2022260064A5 true JPWO2022260064A5 (cg-RX-API-DMAC7.html) | 2025-06-17 |
Family
ID=84426023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527886A Pending JPWO2022260064A1 (cg-RX-API-DMAC7.html) | 2021-06-08 | 2022-06-08 |
Country Status (12)
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2012012421A (es) | 2010-04-28 | 2012-12-17 | Astellas Pharma Inc | Compuestos tetrahidrobenzotiofena. |
| EP2591354B1 (en) | 2010-07-07 | 2016-09-07 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| PL2772490T3 (pl) | 2011-10-27 | 2016-11-30 | Aminoalkilo-podstawiona pochodna n-tienylobenzamidu | |
| WO2014003153A1 (ja) | 2012-06-28 | 2014-01-03 | 協和発酵キリン株式会社 | 置換アミド化合物 |
| AU2014230552B2 (en) * | 2013-03-13 | 2017-11-16 | Chugai Seiyaku Kabushiki Kaisha | Dihydropyridazine-3,5-dione derivative |
| US9499553B2 (en) * | 2013-03-13 | 2016-11-22 | Chugai Seiyaku Kabushiki Kaisha | Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same |
| SMT202100481T1 (it) | 2014-08-18 | 2021-09-14 | Alkermes Pharma Ireland Ltd | Composizioni per profarmaci di aripiprazolo |
| EP4374877A3 (en) | 2014-09-12 | 2024-07-17 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical containing sodium-dependent phosphate transporter inhibitor and phosphorus adsorbent for use in the prevention, treatment or suppression of chronic kidney disease, arteriosclerosis associated with vascular calcification, or ectopic calcification. |
| MX376202B (es) | 2016-08-15 | 2025-03-07 | Lilly Co Eli | Compuestos de tiofeno condensado utiles como inhibidores de napi-iib. |
| WO2019060604A1 (en) * | 2017-09-20 | 2019-03-28 | Teva Branded Pharmaceutical Products R&D, Inc. | INHALABLE MEDICINE |
| US12097204B2 (en) * | 2018-09-03 | 2024-09-24 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Solid pharmaceutical composition containing 1,3,5-triazine derivative or salt thereof |
-
2022
- 2022-06-08 WO PCT/JP2022/023076 patent/WO2022260064A1/ja not_active Ceased
- 2022-06-08 KR KR1020237045200A patent/KR20240018523A/ko active Pending
- 2022-06-08 US US18/567,435 patent/US20240293402A1/en active Pending
- 2022-06-08 AU AU2022288895A patent/AU2022288895A1/en active Pending
- 2022-06-08 CA CA3221186A patent/CA3221186A1/en active Pending
- 2022-06-08 IL IL309056A patent/IL309056A/en unknown
- 2022-06-08 EP EP22820243.8A patent/EP4353233A4/en active Pending
- 2022-06-08 MX MX2023014507A patent/MX2023014507A/es unknown
- 2022-06-08 CN CN202280041019.3A patent/CN117460511A/zh active Pending
- 2022-06-08 TW TW111121208A patent/TW202317118A/zh unknown
- 2022-06-08 JP JP2023527886A patent/JPWO2022260064A1/ja active Pending
- 2022-06-08 BR BR112023023708A patent/BR112023023708A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7728169B2 (en) | Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use | |
| JP2022542804A5 (cg-RX-API-DMAC7.html) | ||
| AU2008268537B2 (en) | Tableted compositions containing atazanavir | |
| EP2178511A2 (en) | Tableted compositions containing atazanavir | |
| AU2008268625B2 (en) | Tableted compositions containing atazanavir | |
| US9107836B2 (en) | Formulation | |
| US7060854B2 (en) | Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid | |
| EP2178512A2 (en) | Tableted compositions containing atazanavir | |
| WO2019142207A1 (en) | Pharmaceutical compositions comprising ibrutinib | |
| JP2023548855A5 (cg-RX-API-DMAC7.html) | ||
| JP7226697B2 (ja) | ブロナンセリン含有錠剤 | |
| WO2019244171A1 (en) | Stable oral pharmaceutical composition of amorphous empagliflozin and process for preparing thereof | |
| JP2024500545A5 (cg-RX-API-DMAC7.html) | ||
| JP4684545B2 (ja) | 溶出性の良好なイソキサゾール誘導体経口製剤 | |
| US20120121722A1 (en) | Atazanavir formulations | |
| EP1776102A1 (en) | Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation | |
| WO2024084496A1 (en) | Pharmaceutical compositions comprising acalabrutinib maleate | |
| EA049027B1 (ru) | Двухслойная таблетка, содержащая эзетимиб и аторвастатин | |
| AU2004251744B2 (en) | The polymorphic Form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butryric acid | |
| AU2011325235B8 (en) | A composition comprising S-[2-([[1-(2-ethylbutyl)-cyclohexyl]-carbonyl]amino)phenyl]2-methylpropanethioate and croscarmellose sodium | |
| EA045648B1 (ru) | Фармацевтическая композиция, включающая эзомепразол | |
| JP2018203692A (ja) | フェブキソスタット結晶の解砕工程が含まれる、錠剤の製造方法 | |
| HK1082192B (en) | Composition for treating hyperlipidemia |